Society Logo
ME/CFS Australia Ltd

 
Donate ME/CFS Australia (SA) Inc
 

Facebook
 


 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
GPO Box 383,
Adelaide,
South Australia 5001

Office:
266 Port Road,
Hindmarsh,
South Australia 5007
Ph: (08) 8346 3237
('834 MECFS')

Office Hours:
Wednesdays, 10am-3pm

Support Line:
(Mondays and Thursdays,
10am-3pm)
Ph: (08) 8346 3237

SA country callers:
Ph: 1300 128 339
(local call)


FIBROMYALGIA HELP:
Contact
Fibromyalgia SA
at the
Arthritis Foundation of SA
118 Richmond Road,
Marleston 5033
Ph: (08) 8379 5711

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
Why become a member?
Go to Application Form web page
Download Application Form 2013 (PDF, 96KB)

Disturbed metabolic pathways

Sunday 15 July 2012

 

From Research1st:

 

Test tubesDisturbed Metabolic Pathways

Armstrong and colleagues at University of Melbourne published results of a preliminary study analyzing blood samples from 11 CFS patients (2003, Carruthers clinical definition) and 10 non-fatigued controls to identify metabolites as biomarkers for CFS using H NMR spectroscopy. They found significantly decreased levels of glutamine and ornithine in CFS blood samples. They conclude, “Further metabolic analyses … are warranted to improve the knowledge of these metabolite changes and to draw more insight into the underlying biochemical pathways for possible etiologic and clinical significance.” (Clinica Chimica Acta, June 15, 2012)

 

The above originally appeared here.

 


 

blog comments powered by Disqus
Previous Previous Page